Rising Star: Goodwin's Heath Ingram
Heath Ingram of Goodwin Procter LLP advised Avadel Pharmaceuticals on its launch of a U.S. Food and Drug Administration-approved narcolepsy drug and then its $2.37 billion sale to fellow Irish drugmaker...To view the full article, register now.
Already a subscriber? Click here to view full article